Stemcell United Limited Stock Australian S.E.
Equities
BP8
AU000000SCU9
Biotechnology & Medical Research
Sales 2022 | 14.35M 9.32M | Sales 2023 | 339 220.19 | Capitalization | 3.85M 2.5M |
---|---|---|---|---|---|
Net income 2022 | -3M -1.95M | Net income 2023 | -4M -2.6M | EV / Sales 2022 | 1.07 x |
Net Debt 2022 | 627K 407K | Net cash position 2023 | 511K 332K | EV / Sales 2023 | 9,862 x |
P/E ratio 2022 |
-3.98
x | P/E ratio 2023 |
-0.72
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 35.24% |
Managers | Title | Age | Since |
---|---|---|---|
Matthew Leonard
CEO | Chief Executive Officer | 53 | 23-03-29 |
Justyn Stedwell
SEC | Corporate Secretary | - | Apr. 10 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | - | 21-07-20 | |
Paul Stephenson
CHM | Chairman | 63 | 20-03-30 |
Yan Hua Huang
BRD | Director/Board Member | - | 19-05-26 |
1st Jan change | Capi. | |
---|---|---|
+4.09% | 43.43B | |
+47.81% | 41.69B | |
+9.45% | 41.31B | |
-10.92% | 27.14B | |
+9.32% | 25.28B | |
-24.87% | 18.47B | |
+29.70% | 12.59B | |
+1.28% | 12.33B | |
+7.78% | 11.03B |